Therapeutic potential of targeting IL-17 and IL-23 in sepsis - Wikidata - awgldk - TriplyDB

Therapeutic potential of targeting IL-17 and IL-23 in sepsis

Therapeutic potential of targeting IL-17 and IL-23 in sepsis

http://www.wikidata.org/entity/Q36555432

about

Role of cytokines as a double-edged sword in sepsis Septic Shock in Advanced Age: Transcriptome Analysis Reveals Altered Molecular Signatures in Neutrophil Granulocytes.Milk fat globule-epidermal growth factor-factor VIII downregulates interleukin-17 expression in sepsis by modulating STAT3 activation.AMP-activated protein kinase and Glycogen Synthase Kinase 3β modulate the severity of sepsis-induced lung injury.CD11c+ alveolar macrophages are a source of IL-23 during lipopolysaccharide-induced acute lung injury.Cytokine Kinetics in Febrile Neutropenic Children: Insights on the Usefulness as Sepsis Biomarkers, Influence of Filgrastim, and Behavior of the IL-23/IL-17 Pathway.Gene Expression Profile of Human Cytokines in Response to Burkholderia pseudomallei Infection.Thymic Stromal Lymphopoietin Improves Survival and Reduces Inflammation in Sepsis.Innate Lymphoid Cells Are the Predominant Source of IL-17A during the Early Pathogenesis of Acute Respiratory Distress Syndrome.Alterations of serum cytokine levels and their relation with inflammatory markers in candidemia.Oral neutrophils are an independent marker of the systemic inflammatory response after cardiac bypass.IL-36 receptor antagonist with special emphasis on IL-38.Complement After Trauma: Suturing Innate and Adaptive Immunity

P2860

Q35230688-AAE642D5-462C-44A8-B714-37C99EAA34C1 Q35654462-B0211F85-3984-4700-A3DF-7B58682E4E74 Q36447748-2C40F846-669E-4268-AE32-BE3D1B309BB6 Q36757995-62AB526B-1397-4069-A829-40E201220272 Q36828989-A3F7D148-3AE3-4849-A5AF-B8C271F8D092 Q40044862-360C5C1A-C24B-41C1-9B69-88E413CCA9E2 Q40059931-22C76D32-9221-41C8-BA82-E3596E001503 Q40770616-936ABC75-14F0-477C-B98C-5152687C288E Q40942694-97361A86-0A2A-46DF-98A3-6917DE921B9F Q41518398-174F771A-6089-4674-ACD4-5E77BC9420B4 Q41686993-35B05D56-7A86-4597-9108-39454CD412C7 Q45717455-9BAFFB7C-33E6-4962-B013-50A604CC32C4 Q57492399-71062B68-E50B-4AD8-B395-BD373DE060EC

P2860

Therapeutic potential of targeting IL-17 and IL-23 in sepsis

http://www.wikidata.org/entity/Q36555432

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Therapeutic potential of targeting IL-17 and IL-23 in sepsis

@ast

Therapeutic potential of targeting IL-17 and IL-23 in sepsis

@en

type

label

Therapeutic potential of targeting IL-17 and IL-23 in sepsis

@ast

Therapeutic potential of targeting IL-17 and IL-23 in sepsis

@en

prefLabel

Therapeutic potential of targeting IL-17 and IL-23 in sepsis

@ast

Therapeutic potential of targeting IL-17 and IL-23 in sepsis

@en

P1433

Q36555432-229D9CDA-E3EF-4533-AAF6-BD59E5325ABA

P1476

Q36555432-FC24746C-5C5C-4FEF-A9D7-B992E82190C2

P2093

Q36555432-1A6B531D-420F-4885-8E3C-74DE29DCF072

P2860

Q36555432-08176C84-FB1D-4A29-9685-F0CA3A9635D5

Q36555432-099E2649-669B-40D5-ADB5-59FDE4536E49

Q36555432-13DC68F5-7BA8-4144-A494-6148320D2353

Q36555432-223143F8-7498-48A4-A7C7-D6E868B8CD50

Q36555432-23970194-6002-4C7F-AD2C-D3EE2A733FD4

Q36555432-2C659224-E952-4F5F-B3FC-22E1DBD7CA92

Q36555432-379F75F4-B3F4-4E5A-82C5-A2816993B457

Q36555432-39BAF675-58E8-43E3-9A29-174EC1F9927E

Q36555432-40AF070E-A27F-42BE-86F1-A8B746CCC336

Q36555432-4A17E7A8-5647-4E39-9EF7-B6899A2F9CDB

P2888

Q36555432-EE48BD9F-D8EA-4069-97B5-1D03489A5D8D

P304

Q36555432-8BB3CD18-7DAE-48EC-A217-0CD4AF40A3FF

P31

Q36555432-CC61D6E4-725D-4FA9-995D-001A80ACE196

P356

Q36555432-E23BC68A-CE81-4534-872A-2C03808B0803

P433

Q36555432-DA9F09F7-F9A2-41B8-9657-B259DD97AC8D

P478

Q36555432-36D7711A-1FB4-4608-A53D-7D60D7221FC7

P50

Q36555432-07064409-0FA5-4558-900F-1BF206D45C96

P577

Q36555432-24975044-3CF9-4772-ABEA-E0216480D280

P5875

Q36555432-781903CD-B87D-44BE-ABD3-1C72751D1C4F

P6179

Q36555432-93ACC04E-7BC7-43C7-98DD-0324670F8687

P698

Q36555432-409D1A58-6757-4BA0-871B-CD56C18F1E4A

P921

Q36555432-4B24D673-EFD4-49FB-9CD6-F657011F8086

P932

Q36555432-D356726C-6132-4421-88C0-817C1D77B552

P356

P1433

Clinical and translational medicine

P1476

Therapeutic potential of targeting IL-17 and IL-23 in sepsis

@en

P2093

Markus Bosmann

http://www.w3.org/2001/XMLSchema#string

P2860

Human IL-17: a novel cytokine derived from T cells

CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene

T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells

Transforming growth factor-beta induces development of the T(H)17 lineage

Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis

Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation

Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome

P2888

P304

4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/2001-1326-1-4

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235390227

http://www.w3.org/2001/XMLSchema#string

P6179

1015707448

http://www.w3.org/2001/XMLSchema#string

P698

23369364

http://www.w3.org/2001/XMLSchema#string

P921

P932

3552565

http://www.w3.org/2001/XMLSchema#string